Table 1.
Patients characteristics
| Characteristic | Value |
|---|---|
| Patients | 58 (100) |
| Age (yr) | 67.4±7.5 |
| Male | 45 (77.6) |
| Female | 13 (22.4) |
| Comorbidity | |
| Alcohol abuse | 36 (62.1) |
| Tobacco abuse | 34 (58.6) |
| Alcohol and tobacco abuse | 24 (41.4) |
| Previous ENT cancer (SCC) | 9 (15.5) |
| Previous esophageal cancer (SCC) | 7 (12.1) |
| Previous radiotherapy of the mediastinum | 7 (12.1) |
| Liver cirrhosis | 11 (19.0) |
| Chronic pancreatitis | 5 (8.6) |
| Ischemic heart disease | 11 (19.0) |
| Chronic obstructive pulmonary disease | 11 (19.0) |
| Peripheral arterial obstructive disease | 8 (13.8) |
| ASA status | |
| 1 | 5 (8.6) |
| 2 | 22 (37.9) |
| 3 | 31 (53.4) |
| Charlson comorbidity index | 5±1.4 |
| Indication for diagnostic endoscopy | |
| Surveillance after SCC (ENT or esophageal) | 15 (25.9) |
| Screening or follow-up for esophageal varices | 6 (10.3) |
| Dysphagia and/or odynophagia | 5 (8.6) |
| Heartburn | 7 (12.1) |
| Other symptoms (gastrointestinal bleeding, anemia, abdominal pain, chest pain, diarrhea, biliopancreatic intervention, etc.) | 19 (32.8) |
| Screening EGD (offered in combination with screening colonoscopy) | 7 (12.1) |
Values are presented as number (%) or mean±standard deviation.
ENT, ear, nose, throat; SCC, squamous cell carcinoma; ASA, American Society of Anesthesiologists; EGD, esophagogastroduodenoscopy.